Clinical Trials Sponsored by Pneumex Corporation

Total 6474 results

Boston Scientific Corporation
PneumRx, Inc.

Completed

Evaluation of the PneumRx Lung Volume Reduction Coil to Treat Emphysema

Emphysema

Germany, Netherlands
Boston Scientific Corporation
PneumRx, Inc.

Terminated

LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009) (CROSSOVER)

Emphysema

United States, Netherlands, France, Canada, United Kingdom
Boston Scientific Corporation
PneumRx, Inc.

Terminated

Post Market Observational, Prospective, Multi-center Study

Emphysema

United Kingdom, Spain, Germany, Switzerland, Austria, Denmark
Boston Scientific Corporation
PneumRx, Inc.

Terminated

Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study (RENEW)

Emphysema

United States, Netherlands, France, Canada, Germany, United Kingdom
Boston Scientific Corporation
PneumRx, Inc.

Completed

Evaluation of Physiologic Parameters to Study the Mechanism of Action of the Lung Volume Reduction Coil in Subjects With Homogeneous Emphysema

Emphysema

Netherlands
Boston Scientific Corporation
PneumRx, Inc.

Completed

Study of PneumRx Endobronchial Coil System in Treatment of Subjects With Severe Emphysema (ELEVATE)

Emphysema

United Kingdom, France, Germany, Netherlands, Italy, Austria
Boston Scientific Corporation
PneumRx, Inc.

Completed

Randomized Comparison of the RePneu Lung Volume Reduction Coil (LVRC) to Standard of Care for the Treatment of Emphysema (RESET Study)

Emphysema

United Kingdom
Boston Scientific Corporation
PneumRx, Inc.

Completed

Feasibility Study of PneumRx's Lung Volume Reduction Coil (LVRC)

Emphysema

Netherlands, Germany, France
Boston Scientific Corporation
PneumRx, Inc.

Terminated

Changes in Lung Physiology and Cardiac Performance in Patients With Emphysema Post Bilateral RePneu Coil Treatment

Emphysema

Germany
Boston Scientific Corporation
PneumRx, Inc.

Terminated

Chronic Obstructive Pulmonary Disease (COPD) Co-Pilot AIR Substudy of CLN0014 (Co-Pilot Air)

COPD Symptoms After Coil Procedure

Switzerland
Michael Wilson & Associates Health Care Consulting...
Pneumex Corporation

Terminated

Low Back Study to Compare Traditional Physical Therapy With Combined Therapy Protocol

Low Back Pain | Radiculopathy

United States
CHU de Reims
PneumRx, Inc.

Unknown

Lung Volume Reduction Coil Treatment in Emphysema. (STICREVOLENS)

Emphysema

France
Groupe Francais De Pneumo-Cancerologie
Baxter Healthcare Corporation; Amgen

Unknown

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer

France
Pneuma Respiratory, Inc

Completed

Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD

COPD

United States
Pneuma Pharmaceuticals Incorporated

Terminated

Calfactant for Direct Acute Respiratory Distress Syndrome (CARDS)

Respiratory Distress Syndrome, Adult

Korea, Republic of, United States, Canada, New Zealand, Australia, Israel
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
HGE Health Care Solutions, LLC
PneumRx, Inc.

Unknown

Evaluation of COPD Co-Pilot

Pulmonary Disease, Chronic Obstructive

United States
HGE Health Care Solutions, LLC
PneumRx, Inc.

Unknown

Evaluation of COPD Co-Pilot

COPD

United States
Institut für Pneumologie Hagen Ambrock eV
PneumRx, Inc.

Completed

Improvement of Sleep Quality by RePneu® Coils in Advanced Pulmonary Emphysema

Emphysema | COPD

Germany
Groupe Francais De Pneumo-Cancerologie

Recruiting

Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion (RESAMEX)

Non-small Cell Lung Cancer | EGFR Exon 20 Insertion Mutation

France
Groupe Francais De Pneumo-Cancerologie

Completed

Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression. (EXPLORE-PDL1)

Lung Cancer

France
Groupe Francais De Pneumo-Cancerologie

Completed

Feasibility of re Biopsies at Progression (GFPC-REBIOP)

Lung Cancer

France
Groupe Francais De Pneumo-Cancerologie

Completed

Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC) (EPNEC)

Large Cell Lung Cancer | Neuroendocrine Carcinoma of Lung (Diagnosis)

France
Groupe Francais De Pneumo-Cancerologie

Completed

Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) (EGFR-RETRO)

NSCLC Non Small Cells Lung Cancer

France
Groupe Francais De Pneumo-Cancerologie

Completed

Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer (OPERAGE)

Carcinoma, Non-Small-Cell Lung

France
Groupe Francais De Pneumo-Cancerologie

Completed

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

France
Groupe Francais De Pneumo-Cancerologie
AstraZeneca

Active, not recruiting

Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE) (OBSTINATE)

Non-Small Cell Lung Cancer

France
Hospital Central Norte PEMEX

Recruiting

Abdominal Binder in Colonoscopies Performed by Trainees

Performance of Colonoscopy | Tolerance of Colonoscopy

Mexico
Groupe Francais De Pneumo-Cancerologie
Takeda

Recruiting

Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC (BIOEXALK)

Non-small Cell Lung Cancer | ALK Gene Rearrangement Positive

France
Hospital Central Sur de Pemex

Terminated

Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia

Arthralgia | Kidney Failure, Chronic

Mexico
Boston Scientific Corporation
Guidant Corporation

Completed

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

Ventricular Fibrillation | Ventricular Tachycardia

France
Boston Scientific Corporation
Guidant Corporation

Completed

Shockless Implant Evaluation (SIMPLE)

Ventricular Fibrillation | Ventricular Tachycardia

Germany, Spain, Canada, Israel, Netherlands, France, Finland, United Kingdom, Austria, Malaysia, Thailand, Hong Kong, Sweden, Hungary, Australia, Czechia, Norway, Poland
Boston Scientific Corporation
Guidant Corporation

Completed

Feature Assessment Study for Indications Based Programming (FASt-IBP)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Flutter

Germany, Spain, Switzerland, China, Austria, Belgium, France, Greece, Latvia, Netherlands, Slovakia
Boston Scientific Corporation
Guidant Corporation

Completed

Japanese Assessment of Indication Based Programming (JASMINE)

Heart Failure | Arrhythmias, Cardiac

Japan
Boston Scientific Corporation
Guidant Corporation

Completed

Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ? (Quick ICD)

Cardiac Arrest

Germany
Rgene Corporation
American BriVision Corporation

Not yet recruiting

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Nonsquamous Nonsmall Cell Neoplasm of Lung

Taiwan
Rgene Corporation
American BriVision Corporation

Not yet recruiting

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Pancreatic Cancer
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA Modul 7 VRR

Atrial Fibrillation

Germany
Boston Scientific Corporation
EKOS Corporation

Completed

ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism (ULTIMA)

Submassive Pulmonary Embolism

Germany, Switzerland
Boston Scientific Corporation
EKOS Corporation

Completed

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism (OPTALYSE PE)

Pulmonary Embolism and Thrombosis

United States, United Kingdom
Boston Scientific Corporation
EKOS Corporation

Completed

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy (SEATTLE II)

Pulmonary Embolism | Acute Pulmonary Embolism | Pulmonary Thromboembolism | Massive Pulmonary Embolism | Sub-massive Pulmonary Embolism

United States
Boston Scientific Corporation
Guidant Corporation

Completed

MODULA Modul 5 BEAT-HF

Heart Failure

Germany
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms

Heart Failure

Germany
Guidant Corporation
Boston Scientific Corporation

Completed

Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following (Cogent-4)

Heart Failure | Ventricular Tachycardia, Ventricular Fibrillation

Israel, Denmark
Neurex

Completed

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

HIV Infections | Pain | Cancer

United States
Boston Scientific Corporation
EKOS Corporation

Withdrawn

Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)

Coronary Artery Disease | Atherosclerosis | Peripheral Artery Disease | Chronic Total Occlusion

United States
Boston Scientific Corporation
EKOS Corporation

Completed

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System (ACCESS PTS)

Deep Vein Thrombosis | Post-thrombotic Syndrome

United States
Guidant Corporation
Boston Scientific Corporation

Completed

Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device (SEPTAL-CRT)

Ventricular Fibrillation | Ventricular Tachycardia | Systolic Heart Failure

France, Spain
Groupe Francais De Pneumo-Cancerologie
Bristol-Myers Squibb

Active, not recruiting

Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE) (MESO-IMMUNE)

Malignant Pleural Mesothelioma | Unresectable Malignant Neoplasm

France
Shanghai Antengene Corporation Limited

Terminated

A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS) (HATCH)

Myelodysplastic Syndrome

China

Clinical Trials Sponsored by Pneumex Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations